Measure | Screening | Baseline | 6 weeks | 3 months | 6 months | 12 months |
---|---|---|---|---|---|---|
Clinical Measures | ||||||
Systolic blood pressure | X | X | X | X | X | X |
Diastolic blood pressure | X | X | X | X | X | X |
Blood sugar | X | |||||
BMI (weight/height) | X | X | X | |||
Weight | X | X | X | X | X | |
Waist circumference | X | X | X | X | X | |
Electrocardiogram | X | X | ||||
Total cholesterol (with lipid profile) | X | X | X | X | ||
LDL (Lipid profile) | X | X | X | X | ||
HDL (Lipid profile) | X | X | X | X | ||
Triglycerides (Lipid profile) | X | X | X | X | ||
Glycosylated hemoglobin | X | X | X | X | ||
Serum creatinine | X | X | X | X | ||
Urine creatinine | X | X | ||||
Urine microalbumin | X | X | ||||
Questionnaires | ||||||
Rose angina questionnaire [104] | X | |||||
The Kessler-10 [81] | X | |||||
Modified Short Blessed Cognitive Test [103] | X | |||||
MINI [82] | X | |||||
PHQ-9 [85] | X | X | X | X | X | |
GAD-7 [84] | X | X | X | X | X | |
Patient perception | X | X | ||||
Fagerstrom Test for Nicotine Dependence (FTND) and FTND-Smokeless Tobacco [105, 106] | X | X | X | X | X | |
Alcohol Use Disorders Identification Test (AUDIT) [107] | X | X | X | X | X | |
Food Frequency [108] | X | X | ||||
International Physical Activity (IPAQ) [109] | X | X | X | X | ||
Medication adherence (VAS) [110] | X | X | X | X | X | |
Diabetes self-management questionnaire [111] | X | X | X | X | X | |
World Health Organization (WHO) Disability Assessment Schedule 2.0 | X | X | ||||
Demographics | X | X | X | X | X | |
Social support [112] | X | X | X | X | ||
WHO Quality of life (WHOQOL-BREF) [113] | X | X | X | |||
Integrated Stigma for Mental Illness Scale (ISMI) [114] | X | X | X | X |